<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02509650</url>
  </required_header>
  <id_info>
    <org_study_id>6024</org_study_id>
    <nct_id>NCT02509650</nct_id>
  </id_info>
  <brief_title>Identification of Mutations Responsible for Rare Familial Skin Diseases by Next Generation Sequencing</brief_title>
  <acronym>DERMA-SEQ</acronym>
  <official_title>Identification of Mutations Responsible for Rare Familial Skin Diseases by Next Generation Sequencing</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Strasbourg, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Strasbourg, France</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary purpose of the protocol is to use next generation sequencing to identify
      pathogenic variants in genes involved in very rare skin diseases.

      The secondary purpose will be to study the genotype-phenotype correlation in order to
      re-evaluate the classification of these disorders. This work could help in the understanding
      of the physiopathology of very rare skin disorders.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2015</start_date>
  <completion_date type="Anticipated">February 2018</completion_date>
  <primary_completion_date type="Anticipated">February 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Number of patients with a deleterious mutation</measure>
    <time_frame>6 months</time_frame>
    <description>Validation of the exome sequencing results will be done by sanger sequencing</description>
  </primary_outcome>
  <enrollment type="Anticipated">25</enrollment>
  <condition>Familial Lipomatosis</condition>
  <condition>Very Rare Dermatologic Diseases</condition>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Whole blood
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Familial lipomatosis
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients affected by familial lipomatosis

          -  patients with rare dermatologic disease without molecular diagnosis

          -  written informed consent is obtained from the patient and his/her family

        Exclusion Criteria:

          -  the patient does not want to participate to the protocol

          -  the patient is already included in another study using next generation sequencing
             technologies
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>2 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Salima EL CHEHADEH, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hôpitaux Universitaires de Strasbourg</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Salima EL CHEHADEH, MD</last_name>
    <phone>33.3.88.12.81.20</phone>
    <email>salima.elchehadeh@chru-strasbourg.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Dan LIPSKER, MD</last_name>
    <phone>33.3.88.11.61.79</phone>
    <email>dan.lipsker@chru-strasbourg.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Fédération de Génétique, Service de Génétique Médicale, Hôpital de Hautepierre, Hôpitaux Universitaires de Strasbourg</name>
      <address>
        <city>Strasbourg</city>
        <zip>67091</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Salima EL CHEHADEH, MD</last_name>
      <phone>33.3.88.12.81.25</phone>
      <email>salima.elchehadeh@chru-strasbourg.fr</email>
    </contact>
    <investigator>
      <last_name>Salima EL CHEHADEH, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Hélène DOLLFUS, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Service de Dermatologie, Hôpital Civil, Hôpitaux Universitaires de Strasbourg</name>
      <address>
        <city>Strasbourg</city>
        <zip>67091</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dan LIPSKER, MD</last_name>
      <phone>33.3.88.11.61.79</phone>
      <email>dan.lipsker@chru-strasbourg.fr</email>
    </contact>
    <investigator>
      <last_name>Dan LIPSKER, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>October 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 15, 2015</study_first_submitted>
  <study_first_submitted_qc>July 27, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 28, 2015</study_first_posted>
  <last_update_submitted>October 7, 2016</last_update_submitted>
  <last_update_submitted_qc>October 7, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 10, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Exome sequencing</keyword>
  <keyword>Skin disease</keyword>
  <keyword>Familial lipomatosis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Skin Diseases</mesh_term>
    <mesh_term>Lipomatosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

